HeartFlow (NAS: HTFL) key facts
- HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary…
- HeartFlow (NAS: HTFL)’s last known valuation is $1.5B (Aug 2025).
- It has raised $1.2B across 2 recorded rounds; the latest was Later Stage VC ($98.4M) in Apr 2025.
- Notable investors include Wellington Management, Bain Capital Life Sciences, Hayfin Capital Management.
- 6 institutional filers report fund marks on HeartFlow (NAS: HTFL) across 62 filings.
- Status: Publicly Held.
Who backs HeartFlow (NAS: HTFL)
3- ·Watch HeartFlow (NAS: HTFL): the Monday email on marks, rounds and moves
HeartFlow (NAS: HTFL) funding rounds
2 roundsHeartFlow (NAS: HTFL) valuation
HeartFlow (NAS: HTFL) is now publicly traded; this page covers its private-market history, where its last recorded valuation was $1.5 billion (Aug 2025). Secondary trades, fund marks and rounds below are the private-market record; the listed share price is not tracked here.
Recent activity
In the last 90 days, HeartFlow (NAS: HTFL)'s record added 7 institutional fund marks (latest period Jul 2026).
How much has HeartFlow (NAS: HTFL) raised?
HeartFlow (NAS: HTFL) has raised $1.2 billion in total; 2 of its rounds are on record. The largest on record was a $98.4 million later-stage round in Apr 2025.
Institutional holders and vehicles
6 SEC-registered funds reported 62 fair-value marks on HeartFlow (NAS: HTFL) between Apr 2025 and Jul 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.
HeartFlow (NAS: HTFL) investors
3 investors are on record for HeartFlow (NAS: HTFL), including Wellington Management, Bain Capital Life Sciences and Hayfin Capital Management. The later-stage round in Apr 2025 drew 8 investors.
Comparable companies
Comparable decision/risk analysis names by valuation on PrivateMarketView: Freenome ($2.2 billion), Anumana ($580 million) and VideaHealth ($400 million).
About HeartFlow (NAS: HTFL)
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, from which it derives maximum revenue from the United States.
- Industry
- Decision/Risk Analysis
- Sector
- Healthcare
- HQ
- Mountain View, CA, United States
- Founded
- 2007
- Employees
- 843
- Website
- heartflow.com/
- Ownership
- Publicly Held
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
HeartFlow (NAS: HTFL)’s last known valuation, Aug 2025. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.
Institutional fund marks on HeartFlow (NAS: HTFL)
6 filers · latest Jul 20266 SEC-registered funds reported 62 fair-value marks on HeartFlow (NAS: HTFL) between Apr 2025 and Jul 2026. Filer-level marks and implied $/share are available to Pro members.
Membership and data by Private Market View